Haematology and Leukaemia

Entry requirements

To discuss the entry requirements for this programme please contact Lisa Crimmins at crimmins@liverpool.ac.uk

Months of entry

Anytime

Course content

The Department of Molecular and Clinical Cancer Medicine (http://www.liv.ac.uk/cancerstudies/) forms the mainstay of the new Liverpool Cancer Research UK Centre (http://www.liverpoolcancercentre.org.uk/). Our principal research themes include basic cancer cell and molecular biology, translational research and tumour specific research in many areas including pancreatic, head and neck cancer, urological, breast, gastro-oesophageal, colorectal, gynaecological and lung cancers as well as paediatric cancers and haemato-oncology. The Department forms an important component of the Liverpool Cancer Research UK Centre andis closely aligned with the Cancer Research UK Liverpool Cancer Trials Unit, the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre (http://www.lctu.org.uk/lecmc/) and the NIHR Pancreas Biomedical Research Unit. In addition, the Department of Molecular and Clinical Cancer Medicine will soon be home to the Marie Curie Palliative Care Institute.

The Research Assessment Exercise 2008 identified particular strengths within the Department (previously known as the School of Cancer Studies) including basic research in cytokinesis and DNA damage response, the molecular and cellular biology of lymphoid and myeloid leukaemias and the genetics of squamous cell carcinoma. Translational research developed around focussed themes such as novel biological therapeutics, and large multi-centre clinical trials in leukaemia and pancreatic cancer was also identified as a particular strength of the Department. Of the total research activity performed within the Department, 50% was deemed to be of world-leading or internationally excellent quality, and a further 50% internationally recognised.

The University has invested over £20million in cancer research which has been used for the creation of several new posts in the Department, and in the establishment of the University of Liverpool Cancer Research Centre (ULCRC) building. This commitment to cancer research has resulted in the launch of Liverpool Cancer Research UK Centre - an organisation that brings together scientists, clinicians and local stakeholders to lead and deliver cancer research of the highest quality and importance.

Research income itself now exceeds £25m and includes funding from Cancer Research UK, Leukaemia and Lymphoma Research, Northwest Cancer Research Fund, Kay Kendal Leukaemia Fund, Wellcome Trust, MRC, NIHR, BBSRC and a number of industrial partners. The Department also enjoys participation within the European Funding Networks.